HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mickleborough, L. L. Articles by Sun, Z. Search for Related Content PubMed PubMed Citation Articles by Mickleborough, L. L. Articles by Sun, Z.

The Annals of Thoracic Surgery, Vol 58, 622-629, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Are patients receiving amiodarone at increased risk for cardiac operations?

LL Mickleborough, H Maruyama, S Mohamed, DC Rappaport, E Downar, J Butany and Z Sun
Department of Surgery, University of Toronto, Ontario, Canada.

Amiodarone therapy has been implicated as a risk factor for cardiothoracic surgical procedures. In patients undergoing map-guided surgical procedures for the treatment of ventricular tachycardia, we compared the perioperative course of those receiving long-term amiodarone therapy (n = 36) versus that in those not receiving the drug (n = 31). The two groups were similar with respect to age, sex, presenting symptoms, functional class, extent of coronary artery disease, presence of a ventricular aneurysm, technique of ventricular tachycardia ablation, cross-clamp or pump time, the number of vessels grafted, the operative fluid balance, and a need for intraaortic balloon pump or inotropic agent support. In 5 patients receiving amiodarone, epinephrine was required to maintain a normal systemic vascular resistance and adequate arterial pressure. Postoperatively, 6 patients (17%) on amiodarone therapy suffered acute respiratory failure. In spite of aggressive therapy, 3 of these patients died. Only 1 patient not receiving amiodarone died of a stroke. We conclude that amiodarone therapy in patients undergoing open heart operations is associated with an increased risk of severe pulmonary complications (p = 0.03 by Fisher's exact test). Amiodarone therapy should be withheld in patients with ventricular tachycardia until they have been assessed as candidates for possible surgical intervention.

This article has been cited by other articles:

				S. M. Bagshaw, P. D. Galbraith, L. B. Mitchell, R. Sauve, D. V. Exner, and W. A. Ghali Prophylactic Amiodarone for Prevention of Atrial Fibrillation After Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2006; 82(5): 1927 - 1937. [Abstract] [Full Text] [PDF]

				A. Sedrakyan, T. Treasure, J. Browne, H. Krumholz, C. Sharpin, and J. van der Meulen Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: Evidence from randomized clinical trials J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 997 - 1005. [Abstract] [Full Text] [PDF]

				J. Kerstein, A. Soodan, M. Qamar, M. Majid, E. Lichstein, G. Hollander, and J. Shani Giving IV and Oral Amiodarone Perioperatively for the Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Surgery: The GAP Study Chest, September 1, 2004; 126(3): 716 - 724. [Abstract] [Full Text] [PDF]

				L. L. Mickleborough, N. Merchant, Y. Provost, S. Carson, and J. Ivanov Ventricular reconstruction for ischemic cardiomyopathy Ann. Thorac. Surg., June 1, 2003; 75(90060): S6 - 12. [Abstract] [Full Text] [PDF]

				W. L. Holman Amiodarone in cardiothoracic surgery patients: What is a surgeon to do? J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 463 - 464. [Full Text] [PDF]

				E. Crystal, S. Kahn, R. Roberts, K. Thorpe, M. Gent, J. A. Cairns, P. Dorian, and S. J. Connolly Long-term amiodarone therapy and the risk of complications after cardiac surgery: Results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT) J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 633 - 637. [Abstract] [Full Text] [PDF]

				S. Kaushik, A. Hussain, P. Clarke, and H. L. Lazar Acute pulmonary toxicity after low-dose amiodarone therapy Ann. Thorac. Surg., November 1, 2001; 72(5): 1760 - 1761. [Abstract] [Full Text] [PDF]

				L. L. Mickleborough, S. Carson, and J. Ivanov Repair of dyskinetic or akinetic left ventricular aneurysm: Results obtained with a modified linear closure J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 675 - 682. [Abstract] [Full Text] [PDF]

				S. J. Connolly Evidence-Based Analysis of Amiodarone Efficacy and Safety Circulation, November 9, 1999; 100(19): 2025 - 2034. [Full Text] [PDF]

				J. A. Gomes, J. Ip, F. Santoni-Rugiu, D. Mehta, A. Ergin, S. Lansman, E. Pe, T. Takle Newhouse, and S. Chao Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study J. Am. Coll. Cardiol., August 1, 1999; 34(2): 334 - 339. [Abstract] [Full Text] [PDF]

				T. O. Cheng and L. L. Mickleborough Amiodarone and Risk of Cardiac Operations Ann. Thorac. Surg., March 1, 1995; 59(3): 784 - 784. [Full Text]